ProteoNic’s expression expertise, services and UNic™ technology toolbox cover a wide range of expression hosts and genes. Products and services are available for expression in (filamentous) fungal, mammalian, plant and yeast host systems.
Pharmaceutical proteins
The production of antibodies and other therapeutic proteins is capital intensive, while quality of the protein product is key. Increasing production yields results in significant cost savings because of
the decrease in variable Cost of Goods as well as capital investment for manufacturing capacity. The demand for production yield improvement is evident in this market; even a 2-fold yield improvement can result in saving millions of dollars per product per year.
Industrial proteins
Hyper competition in this high volume/low margin market creates an urgent need for improving the cost structure. This is best realized by decreasing manufacturing costs as these largely determine the Cost of Goods. An improvement of just a few percentage points will already result in a significantly higher bottom line result and improved competitive advantage.
Other protein industries
Any industry in which a protein is the or a core element of the end product can benefit from the application of UNic™. The increased production yield not only reduces variable production costs, but can also positively impact capital investment (fixed costs) and use of raw materials. In addition it could lead to a shorter production and product development time.